Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Linnaeus Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
Linnaeus Therapeutics's investors include Advanced Research Projects Agency for Health, Kairos Ventures, National Cancer Institute, Penn Medicine Co-Investment Program.
Linnaeus Therapeutics is headquartered in Haddonfield, United States.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Linnaeus Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Linnaeus Therapeutics — Funding & Investors." VCBacked, February 27, 2026, https://www.vcbacked.co/company/linnaeus-therapeutics. Accessed August 15, 2026.
VCBacked. (2026). Linnaeus Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/linnaeus-therapeutics
{{cite web |title=Linnaeus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/linnaeus-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated